The second example of a photo-hydrogen-evolving (PHE) molecular device consisting of a Ru(bpy)32+ (bpy = 2,2′-bipyridine) derivative and a cis-PtCl2 unit has been successfully prepared and characterized to reveal that the PHE activity is quite sensitive to the structural modification at the bridging spacer unit connecting the RuII and PtII centers.
No takes yet. Share an insight, caveat, or question.
Ozawa et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: